REQUEST A DEMO
Total
USD $0.00
Search more companies

Nordaid OU (Estonia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Full name: Nordaid OU Profile Updated: November 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Nordaid OU is based in Estonia, with the head office in Tallinn. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on March 29, 2011. 7 (2024) employees currently work for Nordaid OU. The latest financial highlights indicate a net sales revenue increase of 2.86% in 2024. During that time, Nordaid OU’s total assets decreased by 12.47%. The enterprise’s net profit margin increased by 4.43% in 2024.

Headquarters
Hargmae tn 22 Haabersti linnaosa
Tallinn; Harju county; Postal Code: 13525

Contact Details: Purchase the Nordaid OU report to view the information.

Basic Information
Total Employees:
Purchase the Nordaid OU report to view the information.
Registered Capital:
Purchase the Nordaid OU report to view the information.
Financial Auditors:
Purchase the Nordaid OU report to view the information.
Incorporation Date:
March 29, 2011
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
50.99%
Purchase this report to view the information.
49.01%
Company Performance
Financial values in the chart are available after Nordaid OU report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
2.86%
Total operating revenue
2.86%
Operating profit (EBIT)
63.87%
EBITDA
33.24%
Net Profit (Loss) for the Period
218.28%
Total assets
-12.47%
Total equity
16.44%
Operating Profit Margin (ROS)
3.49%
Net Profit Margin
4.43%
Return on Equity (ROE)
8.96%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?